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ClassiﬁcationOver 50% of HIV+ individuals exhibit neurocognitive impairment and subcortical atrophy, but theproﬁle of brain
abnormalities associatedwith HIV is still poorly understood. Using surface-based shape analyses, wemapped the
3Dproﬁle of subcorticalmorphometry in 63 elderly HIV+participants and 31 uninfected controls. The thalamus,
caudate, putamen, pallidum, hippocampus, amygdala, brainstem, accumbens, callosum and ventricles were seg-
mented from high-resolution MRIs. To investigate shape-based morphometry, we analyzed the Jacobian deter-
minant (JD) and radial distances (RD) deﬁned on each region's surfaces. We also investigated effects of nadir
CD4+ T-cell counts, viral load, time since diagnosis (TSD) and cognition on subcortical morphology. Lastly, we
explored whether HIV+ participants were distinguishable from unaffected controls in a machine learning con-
text. All shape and volume features were included in a random forest (RF) model. The model was validated with
2-fold cross-validation. Volumes of HIV+ participants' bilateral thalamus, left pallidum, left putamen and
callosum were signiﬁcantly reduced while ventricular spaces were enlarged. Signiﬁcant shape variation was
associated with HIV status, TSD and the Wechsler adult intelligence scale. HIV+ people had diffuse atrophy,
particularly in the caudate, putamen, hippocampus and thalamus. Unexpectedly, extended TSD was associated
with increased thickness of the anterior right pallidum. In the classiﬁcation of HIV+ participants vs. controls,
our RF model attained an area under the curve of 72%.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Combined antiretroviral therapy (cART) has vastly improved the
quality of life for people infected with human immunodeﬁciency virus
(HIV), allowing many to live to an advanced age. The over 55 demo-
graphic is the most rapidly growing age group of HIV+ individuals
(Hall et al., 2008). Yet, following the increased life expectancy, numerous
reports studying chronic infection indicate that HIV positivity indepen-
dently contributes to and synergistically exacerbates age-related neuro-
degeneration (Canizares et al., 2014; Cohen et al., 2015) which in many
cases results in dramatic cognitive declines and decreased quality of life,
with upwards of 50% proceeding to develop a degree of HIV-associated
neurocognitive disorders (HAND) (Cysique et al., 2004; Simioni et al.,eterminant; CD4, cluster of
niversity of Southern California,
. This is an open access article under2010). Several potential mechanisms for neuronal atrophy have been re-
ported including chronic inﬂammation, interrupted metabolic processes,
immunological senescence, heightened risk for cardiovascular disorders
and even side effects of cART. For a more detailed review of these factors
we refer the reader to Canizares et al. (2014).
Numerous studies support the view that central nervous system in-
fection parallels the aging process. The Multicenter AIDS Cohort Study
(MACS), implementing a longitudinal study with a 5-year follow-up,
identiﬁed an interaction between HIV status, age and time whereby
middle-aged and elderly infected participants exhibited a signiﬁcant
decline in executive function over time relative to uninfected controls
who showed no reduction in performance with respect to time (Sacktor
et al., 2010). In contrast, (Cysique et al., 2011) observed that age and
HIV status independently contributed to cognitive decline but were un-
able replicate an interaction between the two.
Literature from structural MRI widely reports age disproportionate
degrees of atrophy among HIV+ cohorts (Becker et al., 2012;
Thompson et al., 2005; Towgood et al., 2012) have reported boththe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Demographic and clinical characteristics.
Patients, N = 63 Controls, N = 31
Demographics
Age, mean (SD), y 64.68 (4.57) 65.35 (2.21)
Gender (M/F) 61/2 27/4
Adjusted education, years* 16.09 (2.25) 17.53 (2.09)
Clinical information
CD4, mean (SD), cells/mm3 516.44 (212.30) –
Nadir CD4, mean (SD), cells/mm3 204.96 (154.85) –
Time since diagnosis, mean (SD), y 20.39 (6.31) –
Viral load, mean (SD), copies/mm3 16,380.58 (76,418.68) –
Detectable viral load, yes/no 24/39 –
Receiving cART, yes/no 63/0 –
History of diabetes 8 0
History of depression* 28 8
APOE allele, yes/no/unknown 12/51/0 6/13/12
Cognitive information
ANI 14 –
MND 16 –
HAD 0 –
WAIS score, mean (SD)* 48.77 (10.73) 57.27 (7.48)
WRAT score, mean (SD)* 64.05 (4.26) 66.50 (1.93)
Substance abuse history none/recent/remote
Marijuana 61/0/2 –
Cocaine 55/0/8 –
Crack 62/0/1 –
Meth 57/0/6 –
Alcohol 50/0/13 –
Abbreviations: ANI = Asymptomatic Neurocognitive Impairment; MND = Mild
Neurocognitive Disorder; HIV-associated Dementia. *Signiﬁcant difference between HIV
status. WAIS = Wechsler Adult Intelligence Scale; scores available for N = 57 patients
and N = 22 controls. WRAT =Wide Range Achievement Test; scores available for N =
57 patients and N = 20 controls.
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ed reductions in subcortical structures are also widely reported
(Ances et al., 2012). Diffusion tensor imaging has revealed interac-
tive effects of HIV status and age in the reduction of fractional an-
isotropy and increase of mean diffusivity within subcortical white
matter and frontal regions (Chen et al., 2009). Magnetic resonance
spectroscopy reports also suggest that CNS HIV infection mimics
the effects of aging. (Chang et al., 2004; Harezlak et al., 2011) both
reported higher choline compounds (CHO) : total creatine (CR)
and myoinositol (MI) : CR ratios in the basal ganglia associated
with aging and HIV status.
Given the complications presented by the synergistic effects of aging
and HIV, it is important to further understand themorphological differ-
ences that occur between normal aging and aging inﬂuenced by HIV in-
fection. While several studies have investigated volumetric differences
in elderly HIV+ cohorts, a thorough description of shape differences
in elderly HIV+ subjects remains to be explored. Local descriptions of
shape variation may offer an additional characterization of HIV-related
neurodegeneration by describing localized regions of tissue atrophy
and expansion. This level of description could be leveraged as an addi-
tional biomarker for the detection of aberrant degeneration, allowing
clinicians to offer more targeted interventions when needed.
We report on both the subcortical volumetric and 3D surface-based
shape abnormalities in a cohort of 63 elderly HIV+ subjects scanned
with high-resolution structural magnetic resonance imaging (MRI) as
part of the UCSF (University of California, San Francisco) HIV Over 60
Cohort study. To study subcortical shape, we analyzed: (1) the log of
the Jacobian determinant (JD) indexed over structures' surface coordi-
nates and (2) radial distances (RD) of structure surfaces from a medial
curve. JD maps indicate localized atrophy or dilation of a surface area.
Complementary to JD, RD indicates the local “thickness” of the structure.
We tested associations of morphological descriptors with neuropsycho-
logical measures: the Wechsler Adult Intelligence Scale (WAIS) and
Wide Range Achievement Test (WRAT) scale. We also tested for associ-
ations with several common HIV clinical indices: nadir CD4+ T-cell
count (nCD4), time since diagnosis (TSD; in years), and HIV RNA level
in plasma. We hypothesized that subcortical shape analysis would re-
veal regions of signiﬁcant atrophy in HIV+ people relative to matched
controls and in relation to clinical markers of HIV.
We additionally explored the use of shape and volume features in a
machine learning framework to classify participants as HIV+ or HIV−
using a random forest (RF) classiﬁer; a class of supervised machine
learning algorithms that has gained popularity for its accuracy, ease of
use, and computational efﬁciency. Here, the application of machine
learning based on brain morphometry is not intended as a potential
means of clinical HIV diagnosis; rather the ability to robustly distinguish
HIV status based on brain-derived measures would validate that ob-
served differences are highly associatedwith infection status and poten-
tially relevant to the prediction of further HIV-related neurological
atrophy. To our knowledge this is the ﬁrst study to explore classiﬁcation
of HIV status based solely on brain morphometry.
2. Methods
2.1. Subjects
A sample of 63 elderly HIV+ subjects (2 female; age = 64.68 ±
4.57) and 31 uninfected elderly controls (4 female; age = 65.35 ±
2.21) were recruited as part of a San Francisco Bay Area study of elderly
people with HIV. HIV+ participants had an average nCD4 count of
204.96 ± 154.85 cells/mm3, an average TSD of 20.39 years ± 6.31
years. 24 HIV+ participants had detectable levels of viral RNA (above
50 copies/mm3). Among those with detectable HIV RNA, the average
viral load was 16,380.58 ± 76,418.68 copies/mm3. All subjects gave in-
formed consent to take part in the study. Table 1 outlines the demo-
graphic and clinical characteristics of the participants.2.2. Image acquisition
Each subject underwent a whole-brain high-resolution magnetic
resonance imaging (MRI) anatomical brain scan on a Siemens 3 Tesla
TIM Trio scanner with a 12-channel head coil. T1-weighted MP-RAGE
sequences (240 × 256 matrix; FOV = 256 mm; 160 slices; voxel
size = 1.0 × 1.0 × 1.0 mm3; TI = 900 ms; TR = 2300 ms; TE =
2.98 ms; ﬂip angle = 9°).2.3. Morphological descriptors
Previously validated FreeSurfer (Fischl et al., 2002) workﬂows, in-
cluding non-brain tissue removal, intensity normalization and automat-
ed volumetric parcellation based on probabilistic information from
manually labeled training sets, were used to segment the bilateral thal-
amus, putamen, pallidum, amygdala, accumbens, caudate and hippo-
campus from the raw MRIs. All segmentations were visually inspected
to ensure their quality.
The parameterization of each surface was obtained using the “medi-
al demons” method detailed in (Gutman et al., 2012; Gutman et al.,
2015). Brieﬂy, each surface was conformally mapped to the spherical
domain. The spherical maps were rigidly rotated to a probabilistic
atlas. Next, Spherical Demons (SD) (Gutman et al., 2013) was used to
non-linearly register the spherical maps on the basis of curvature. Two
surface-based functionswere deﬁned to do this;ﬁrst, the global orienta-
tion function, deﬁning the direction of the surface and, secondly, the
local thickness of the surface with respect to a skeletonized medial
core. Finally, SD was implemented again using both the newly deﬁned
medial core in conjunction with surface-based curvature to match
each surface to the atlas.
From this process, two shape features are deﬁned at each vertex:
1) radial distance (RD), a proxy for thickness and2) the log of the Jacobian
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14 brain region surfaces, there were a total of 27,120 vertices.
2.4. Statistical methods
Multiple linear regression was used to model inﬂuences of HIV sta-
tus, nCD4 count, viral load, TSD, HAND status and drug abuse history
on the morphometry of each surfaces. The general linear model as-
sumed the following form,
Y ¼ β0 þ β1 Main Effectþ β2  Ageþ β3  Sexþ β4  ICVþ ϵ ð1Þ
where Y is global volume, for one of the regions, or the locally computed
JD or RD;Main Effect is one of HIV status, nCD4 count, viral load or TSD,
HANDor drug abuse history. Thismodel wasﬁtted at each of the surface
vertices when the outcome of interest was the shapemeasure, JD or RD.
HIV status and viral loadwere eachmodeled dichotomously; HIV status
was coded as positive or negative and viral load as detectable (above 50
viral RNA copies/mm3) or undetectable (i.e., binary). nCD4 and TSD
were modeled continuously. HAND status and drug abuse history were
modeled as positive or negative. HAND encompasses a range of im-
pairments including asymptomatic neurocognitive impairment (ANI),
mild neurocognitive disorder (MND) and HIV-associated dementia
(HAD); a subject having any of these was considered HAND positive in
the regressionmodel. Similarly, due to the small number of subjects hav-
ing a history of drug abuse we simply model any of, marijuana, cocaine,
crack or methamphetamine as having a history of abuse.
Associations ofmorphometry and cognitivemeasuresweremodeled
using the following general linear model,
Y ¼ β0 þ β1 Main Effectþ β2  HIV Statusþ β3  Ageþ β4  Sex
þ β5  ICVþ β5  Main Effect HIV Statusð Þ þ ϵ ð2Þ
where Main Effect is one ofWAIS orWRAT scoremodeled continuously
and HIV Status is a dichotomous term.
We controlled formultiple comparisons using the standard false dis-
covery rate (FDR) method with a false-positive rate of 5% (q = 0.05)
(Benjamini and Hochberg, 1995). FDR was performed separately for
volumetric and shape-based tests. For the family of volumetric
tests, FDR was applied to the set of all subcortical structures. For
shape analyses we applied an FDR correction within the family ofFig. 1. Scatterplot of volumetric differences between HIV+ and HIV− participants. The plots ar
right hemisphere (bottom). All plots have been centered and scaled. The HIV status coefﬁcient
FDR correction are highlighted in red.all tests performed on a single surface; correcting for separate testswithin
each surface.
2.5. Random forest classiﬁcation
In addition to mapping differences in subcortical morphometry, we
wanted to investigate the efﬁcacy of our morphometric descriptors as
input features in a machine learning, classiﬁcation context. Here, we
describe the RF framework used in this study.
Developed and detailed by (Breiman, 2001), RFs are supervised
classiﬁers composed of an ensemble of classiﬁcation and regression
trees (CART) and use the majority vote of its terminal nodes to predict
the class of a given observation. RF CARTs are constructed from a
bootstrapped sample of approximately 2/3 of the original observations.
At each node of the CART, a random subset of
ﬃﬃﬃﬃﬃ
M
p
features is assessed.
Here the Gini impurity index is calculated for each feature at the given
node, v. Gini(v) is given by
Gini vð Þ ¼
XC
C¼1
p^vc 1−p^
v
c
  ð3Þ
where p^vc is the proportion of observations belonging to class C at node v.
The objective of the RF algorithm is to split each CART node by the fea-
ture Xiwhich maximizes the class purity of the resultant child nodes, vr
and vl. This is done by choosing the maximum Gain(Xi, v) given by,
Gain Xi; vð Þ ¼ Gini Xi; vð Þ− ωlGini Xi; vl
 
−ωrGini Xi; vrð Þ; ð4Þ
where ωl and ωr are the proportions of observations in node v assigned
to child nodes vr and vl, respectively. The importance I, of feature Xi is
given by the summation of the decreases in the Gini index at each
node where the CART was partitioned by Xi (Gray et al., 2013). That is,
IXi ¼
1
total tree number
X
v∈SXi
Gain Xi; vð Þ; ð5Þ
where SXi indicates the set of all nodes split by Xi. Each CART was grown
to its full, unpruned extent.
Our RF model was implemented in R (R. Core Team, 2014) and used
the RRF package (Deng, 2013). The RF was composed of 5000 trees. We
trained the model on half of the participants, stratiﬁed by HIV status,e divided into rows showing structures in the left hemisphere (top), midline (middle) and
(in mm3) resulting from Eq. (1) is given for each plot. Volumetric differences that survive
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of 28 HIV+ and 15 HIV− participants while the test set included 27
HIV+ and 15 HIV− participants. The RF model was constructed using
a combination of all morphological features; all volumetric, RD and JD
values were entered as predictors of HIV status.
The signiﬁcance of the RF was assessed using a permutation test.
Thiswas done by ﬁrst computing the observed area under (AUC) the re-
ceiver operating characteristic curve (ROC) from the prediction of the
test set. This obser+ved AUC was compared to a null distribution of
1000 AUC values resulting from the classiﬁcation of HIV status based
on randomly shufﬂing the labels associated with the observed predic-
tion. The proportion of AUCs in the null distribution that were larger
than the observed AUC is the p-value associated with the null hypothe-
sis that the observed AUC is less than or equal to 50%, i.e. classiﬁcation is
no better than chance.
As a follow-up analysis we constructed RF classiﬁers on feature
sets composed uniquely of either RD, JD or volumetric measures. We
corrected for the set of all classiﬁer p-values using FDR correction for
multiple comparisons.Fig. 2. FDR-thresholded t-value maps of the HIV+ vs. HIV− contrast. (a) maps the signiﬁca
radiological orientation (i.e. left-right ﬂipped), orientations are provided beside each set of sur3. Results
We found several associations between subcortical morphometry
andHIV status and clinical parameters. In the following sectionswe out-
line the observed morphometry associated with HIV status, nadir CD4
count, detectability of viral load and TSD.
3.1. HIV status
Volumetrically, the callosum (βdx=−290,−10.7%, t =−2.81, p b
0.05), left pallidum (βdx = −180, −7.6%, t = −3.47, p b 0.01), left
putamen (βdx = −330, −5.7%, t = −2.40, p b 0.05), left thalamus
(βdx = −390, −5.9%, t = −2.91, p b 0.05) and right thalamus
(βdx=−440,−6.3%, t=−3.00, p b 0.05)were all signiﬁcantly smaller
in HIV+ participants. Ventricular spaces were, on average, enlarged in
HIV+ subjects. Speciﬁcally, the left lateral (βdx = 5100, 12.7%, t =
2.88, p b 0.05), right lateral (βdx = 3900, 8%, t = 2.41, p b 0.05) and
third (βdx = 420, 15.5%, t = 3.68, p b 0.01) ventricular spaces were all
signiﬁcantly larger in HIV+ participants. Fig. 1 illustrates volumetricnt differences in RD while (b) maps signiﬁcant differences in JD. Images are shown in
faces.
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ric measures are in mm3.
Shapemapping revealedwidespread regions of atrophy in theHIV+
cohort. Speciﬁcally, RD maps, illustrated in Fig. 2(a), identiﬁed signiﬁ-
cant atrophy of the bilateral medial aspect of the caudate head; regions
of atrophy and expansion were observed in the posterior tail regions as
well. Several regions of the bilateral pallidum, left putamen and right
inferior thalamus and inferior hippocampus were also signiﬁcantly
atrophied in HIV+ participants. JD mapping, depicted in Fig. 2(b),
corroborated the observed widespread atrophy in a set of regions only
partially overlapping with those found in the RD maps. The JD maps
highlight atrophy laterally and medially in the bilateral thalamus, ante-
riorly in the left putamen and right accumbens and in the inferior–pos-
terior right hippocampus. Morphometry differences outside of these
regions were below the set statistical threshold of signiﬁcance.
3.2. Nadir CD4+ counts
There were no detectable volumetric or shape-based associations
between nCD4 counts and morphometry.
3.3. Viral load
No signiﬁcant shape or volume differences were found between
HIV+ participants with and without detectable viral RNA levels.
3.4. Time since diagnosis
The volume of the right pallidum (βduration=6.3, t = 2.43, p N 0.05)
was positively associatedwith TSD prior to correction formultiple com-
parisons but failed to survive FDR. Corroborating this, both RD and JD
maps of the right pallidum indicate signiﬁcant local expansion in itsFig. 3. FDR-thresholded t-value maps of the association between TSD and (a) RD and (b) JD.
anterior view while the second is the medial view of the right hemisphere structures.anterior aspect in relation to increased TSD; RD and JD results survived
FDR (see Fig. 3).3.5. Drug abuse history
No signiﬁcant associationswere found between brainmorphometry
and drug abuse history.3.6. HIV-associated neurocognitive disorder
HAND revealed noobservable associationswith brainmorphometry.3.7. Cognitive measures
Both WAIS and WRAT scores were signiﬁcantly larger in the HIV−
cohort, t(54) = −3.97, and t(70) = −3.43, respectively, both p b
0.001. The interaction of HIV status and WAIS or WRAT score was not
signiﬁcantly associated with volume. However, the thickness of the
left caudate was widely associated with the interaction of HIV status
and WAIS score. Fig. 4 maps both the main effect of WAIS score
(c–d) and the interaction of HIV status and WAIS score (a–b) on
subcortical thickness. Fig. 4(c–d) indicates that WAIS is signiﬁcantly
positively associated with left caudate thickness in the control
group. Fig. 4(a–b) indicates that the magnitude of the association
is signiﬁcantly reduced in the HIV+ cohort. The direction of the as-
sociation between thickness and WAIS score is shown to be inverse
in (e–f), which maps the association only within HIV+ participants.
No signiﬁcant associations between shape and WRAT score were
observed.Images are in radiological orientation (i.e. left–right ﬂipped). The ﬁrst column shows an
Fig. 4. FDR-thresholded t-valuemaps of (a–b) association of thickness and the interaction ofWAIS score and HIV Status, (c–d) themain effect ofWAIS on thickness and (e–f) the association of
WAIS and thickness within the HIV+ cohort only.
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Classiﬁcation of HIV status using the full set of morphology descrip-
torswith a 2-fold cross validation yielded an area under the receiver op-
erating characteristic (ROC) curve (AUC) of 72.3% (q= 0. 025). We also
used a more computationally expensive leave-one-out cross validation,
but this did not improve our classiﬁer's performance, giving an AUC of
71.9%. Again, using 2-fold cross validation, we investigated the perfor-
mance of feature subsets comprised exclusively of one of, volume, RD
or JD features. Fig. 5 plots the ROC curves for each set of classiﬁer inputs.
The volumetric subset afforded an AUC of 70.4% (q = 0.025); RD 72.3%
(q = 0. 025) and JD 65.8% (q = 0.080).
In Fig. 6 we mapped the importance scores of each RD and JD value
derived from the RF model to the corresponding surface location, pro-
viding a visual representation of how each region's shape-based mor-
phometry drove the RF model. Fig. 7 complements this by plotting the
importance score for each region; RD and JD-based importance scores
were averaged within each surface. Fig. 7 indicates that RD features
were weighted more heavily than their JD counterparts. We also notethat the only volumetric measure that was relevant to the RF was the
left pallidum. Comparing Fig. 6 to 2, there iswidespread correspondence
between regions considered important to the RF classiﬁer and regions
that were statistically signiﬁcant in modeling the effects of HIV. While
this is perhaps not surprising, it serves to validate both sets of ﬁndings.
4. Discussion
The development of cART has allowed for HIV infected individuals to
live to advanced ages and as a result it is estimated that the proportion
of HIV+ people over the age of 45 years is close to 50% (Collaboration,
A.T.C., 2008) and the demographic of over 55 years is the most rapidly
growing among those with HIV (Cohen et al., 2015; Hall et al., 2008).
While cardiovascular diseases such as stroke and hypertension
(Gorelick et al., 2011) as well as depression (Vink et al., 2009) and dia-
betes (McBean et al., 2004) are all common comorbidities associated
with aging andmay contribute to neurodegeneration, accumulating ev-
idence indicates that HIV exacerbates and uniquely contributes to age-
related neurodegeneration (Holt et al., 2012). Several lines of evidence
Fig. 5. ROC curves and associated AUC values for random forest classiﬁcation using the full
set of morphological features. ROCs for feature subsets are also provided.
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properties that affect cognition and brain aging (Ances et al., 2008;
Robertson et al., 2010; Schweinsburg et al., 2005). The advancing age
of the HIV+ population and the suggested viral contribution to the
aging process underlies the importance of characterizing the progres-
sion of brain atrophy in the older HIV population. The development of
biomarkers to track the extent of the viral effects in the central nervous
system may help to further inform clinicians in selecting the appropri-
ate line of therapy for a particular patient. Using standard volumetric
and novel surface-based shape descriptors we were able to identify
several important HIV-related patterns of brain abnormalities.
Previous studies have noted that HIV has a proclivity for subcortical
regions such as the basal ganglia (Aylward et al., 1993; Aylward et al.,
1995; Berger and Nath, 2000; Gottumukkala et al., 2014) where the
virus may replicate and maintain a reservoir despite active cART thera-
py. Atrophy of these subcortical regions is commonly reported in HIV-
infected individuals. Other reported abnormalities of subcortical struc-
tures include hypermetabolism of the thalamus and basal ganglia
(Drevets, 2001), a reduction in dopaminergic transporters in the puta-
men and striatum and increased mean diffusion in the putamen
(Chang et al., 2008). Corroborating these reported effects, we observed
that HIV positivity was associated with greater subcortical atrophy, par-
ticularly in the caudate, putamen, pallidum, hippocampus and callosum.
Unexpectedly, we observed a dilation in the anterior aspect of the
right pallidum in relation to extended TSD. Several subjects in our
HIV+ cohort had a history of methamphetamine use which has been
linked to enlarged subcortical volumes (Chang et al., 2005; Jernigan
et al., 2005), however we did not observe an association between drug
abuse history and subcortical morphometry. Another possible concern
is that TSD could be confounded by participant age. However, this
seems unlikely given the relatively low standard deviation of age
among the HIV+ cohort (SD = 4.57).
WAIS scores were differentially associated with the thickness of the
left caudate with a positive association within the control group and a
negative associationwithin the HIV+ group. The reason for this inverse
association remains unclear.
We expected to see patterns of morphometry associated with com-
mon clinical measures linked to HIV such as viral load and nadir CD4count, but none of these associations were signiﬁcant. This may be
due, in part, to limited power, as all subjectswere on cARTwith relative-
ly high CD4 counts and either undetectable or very low plasmaHIV RNA
levels. To alleviate this, our ENIGMA consortium is beginning a larger-
scale project to relate clinical markers of HIV disease burden to brain
measures across multiple cohorts (Jean-Paul Fouche et al., 2015).
In addition tomapping abnormal subcorticalmorphometry, we used
the morphological descriptors to predict HIV status in a RF framework.
While a simpler logistic classiﬁer was considered the dimensionality
of our feature set renders these simpler models less tractable and re-
quired initial feature selection and feature scaling to allow convergence.
Given the requirement of extra steps for a logisticmodel and the natural
added value of importance scores, the RFwas a natural choice. This type
of predictive framework helps to verify that observed group differences
robustly distinguish HIV status. Given the precision of a blood test to di-
agnose HIV, classiﬁers based on brain morphometry are not meant to
identify infected individuals; rather the added beneﬁt is the identiﬁca-
tion of potential biomarkers of interest to track the progression of the
deleterious viral effects in the brain. In mapping the importance of
each surface-based feature derived from the RF back onto the subcorti-
cal surfaces, we were able to observe a large degree of correspondence
between thresholded statistical maps and feature importance. This cor-
respondence between importance weightings and statistically differing
regionsmutually validates the observed proﬁle of changes in HIV partic-
ipants as well as the potential to use these regions as biomarkers for
HIV's effect in subcortical brain regions. The exclusive use of RD features
moderately outperformed the exclusive use of volume as predictors,
both of which outperformed the JD-only classiﬁer though no feature-
speciﬁc classiﬁers outperformed another at the alpha = 0.05 level of
signiﬁcance.
Analysis of the importance scores resulting from the random forest
suggests several things. First, we observed that RD (thickness) features
were on average more important than JD or volumetric features. In par-
ticular thickness of the left thalamus, left pallidum and right caudate
were highly important in discerning HIV status. Patterns of importance
were similar for JD features but to lesser extents than RD. The volume of
the left pallidum was the single most informative feature; yet no other
volumetric measures were considered important after taking into ac-
count the shape descriptors.
Because the present study is not longitudinal in design, we are un-
able to address questions of accelerated brain aging caused by HIV.
However, we do observe widespread yet concentrated regions of atro-
phy in the subcortical regions of interest among HIV+ participants
that are age disproportionate. The primary regions of advanced atrophy
seem concentrated in the basal ganglia, thalamus and caudate. This is a
departure from atrophy patterns observed in common forms of neuro-
degeneration such as Alzheimer's disease which principally targets hip-
pocampal regions. However, as previously noted, increased atrophy of
subcortical brain regions has beenwidely reported inHIV neuroimaging
literature. Several studies have also observed decreased cognitive func-
tions in vertically infected children that increase with disease severity
(Chase et al., 2000; Le Doare et al., 2012; Smith et al., 2006) suggesting
that neurological dysfunction is a factor in infection at any age. It would
be tenuous to directly compare observed differences between these age
groups since study designs and protocols differ widely.
We were notably unable to identify a relationship between brain
morphometry and viral load, nCD4 count, HAND status or drug abuse
history. As this is a cohort of elderly subjects, many of whom were in-
fected prior to the development of modern cART yet managed to sur-
vive, the survivorship effect may generally limit our abilities to ﬁnd
such associations; that is it is possible that these individuals are gener-
ally healthier. This also limits our ability to generalize these ﬁndings to
a younger HIV+ population. nCD4 counts have previously been linked
to lower regional brain volumes (Hua et al., 2013) in a younger cohort.
Our lack of observed associations with HAND status also likely reﬂects
the fact that none of our cohort had developed HAD; rather 14 had
Fig. 6.Mapping of random forest importance scores in the classiﬁcation of HIV status to subcortical surfaces. As all features were included in the same RFmodel, their importance is with
respect to all other features. (a) RD and (b) JD feature set importance scores. Images are in radiological orientation (i.e. left–right ﬂipped), orientations are provided beside each set of
surfaces.
571B.S.C. Wade et al. / NeuroImage: Clinical 9 (2015) 564–573ANI while 16 had MND, far milder forms of HAND. Drug abuse history
was similarly limited by the fact that few of our subjects had a history
of drug abuse and those that didwere distributed among different classes
of drugs.
5. Conclusions
We have characterized patterns of abnormal brain morphometry
in an elderly HIV+ cohort. The increased atrophy observed in HIV+
patients lends support to the idea that HIV contributes to age-
disproportionate brain aging. Regions of atrophy were localized by
vertex wise descriptions of thickness, dilation and contraction. Pro-
nounced abnormalities were found in the medial head of the caudate,
the bilateral pallidum and the putamen and the thalamus. Several other
regions exhibited signiﬁcant abnormalities as well. Ventricular spaces
were enlarged in theHIV+cohort.We also observed a paradoxically pos-
itive association between the TSD and the size of the right anteriorpallidum that was not attributable to substance abuse history. This effect
may be a product of medication use or even the survivorship effect, how-
ever neither effect can be evaluated with this cohort as all are on stable
cART and, of course, survivors. Infection status was classiﬁable using
only subcortical morphometry with an AUC of 72.3%. Classiﬁcation was
driven heavily by the thickness of pallidal, thalamic and caudate surfaces.
Future studies should further develop the use of these descriptors to aid in
tracking the progression of HIV's effect on the aging brain.
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